Shih-hsin Lu

Department Of Etiology And Carcinogenesis And State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Genomic characterization and risk stratification of esophageal squamous dysplasia.

Genomic characterization and risk stratification of esophageal squamous dysplasia.

Journal: Medical review (2021)
Published: January 29, 2024

Mammalian esophageal stratified tissue homeostasis is maintained distinctively by the epithelial pluripotent p63+Sox2+ and p63-Sox2+ cell populations.

Mammalian esophageal stratified tissue homeostasis is maintained distinctively by the epithelial pluripotent p63+Sox2+ and p63-Sox2+ cell populations.

Journal: Cellular and molecular life sciences : CMLS
Published: February 15, 2023

Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.

Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.

Journal: European journal of medical research
Published: December 23, 2022

Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia.

Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia.

Journal: Journal of molecular cell biology
Published: April 27, 2022

Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells.

Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells.

Journal: British journal of cancer
Published: January 04, 2021

Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.

Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.

Journal: Carcinogenesis
Published: March 22, 2018

DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells.

DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells.

Journal: Oncotarget
Published: July 12, 2017

TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.

TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.

Journal: Oncotarget
Published: June 07, 2016

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Journal: Scientific reports
Published: November 23, 2015

RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.

RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.

Journal: Cancer letters
Published: March 20, 2014

miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.

miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.

Journal: Stem cells and development
Published: November 14, 2013

Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.

Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.

Journal: Cancer science
Published: October 18, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026